Actively Recruiting
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
Led by Pfizer · Updated on 2026-05-12
173
Participants Needed
19
Research Sites
895 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A study to learn about the long-term safety and efficacy of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B respectively, who have received treatment through prior participation in a Pfizer-sponsored clinical trial. Data collection and participant visits will be based on standard of care.
CONDITIONS
Official Title
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Only participants who received investigational giroctocogene fitelparvovec or fidanacogene eleparvovec and were enrolled in a Pfizer-sponsored study (C0371002, C0371003, C0371005, C3731001, C3731003) are eligible.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 19 locations
1
The Regents of the University of California||UC Davis Health
Rancho Cordova, California, United States, 95670
Actively Recruiting
2
UC Davis Health
Sacramento, California, United States, 95816
Actively Recruiting
3
UC Davis Ambulatory Care Clinic
Sacramento, California, United States, 95817
Actively Recruiting
4
UC Davis Hemophilia Treatment Center
Sacramento, California, United States, 95817
Actively Recruiting
5
UC Davis Medical Center
Sacramento, California, United States, 95817
Actively Recruiting
6
UCSF Outpatient Hematology Clinic
San Francisco, California, United States, 94143
Not Yet Recruiting
7
USF Health Morsani Center For Advanced Healthcare
Tampa, Florida, United States, 33612
Actively Recruiting
8
The University of South Florida Board of Trustees
Tampa, Florida, United States, 33620
Actively Recruiting
9
Mississippi Center For Advanced Medicine
Madison, Mississippi, United States, 39110
Terminated
10
Cornell University||Joan & Sanford I. Weill Medical College
New York, New York, United States, 10065
Actively Recruiting
11
Weill Cornell Medical College-New York Presbyterian Hospital
New York, New York, United States, 10065
Actively Recruiting
12
The Childrens Hospital of Philadelphia Division of Hematology
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
13
Washington Institute for Coagulation
Seattle, Washington, United States, 98101
Not Yet Recruiting
14
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia, 2050
Actively Recruiting
15
Sydney Local Health District (RPAH Zone)
Camperdown, New South Wales, Australia, 2050
Actively Recruiting
16
Kyung Hee University Hospital at Gangdong
Seoul, South Korea, 05278
Not Yet Recruiting
17
Skåne University Hospital
Malmö, Sweden, 21428
Not Yet Recruiting
18
National Taiwan University Hospital
Taipei, Taiwan, 10041
Not Yet Recruiting
19
Ege Universitesi Hastanesi
Izmir, İ̇zmir, Turkey (Türkiye), 35100
Actively Recruiting
Research Team
P
Pfizer CT.gov Call Center
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here